Ventripoint Receives Market Clearance from US-FDA for Complete Heart Analysis System Using 2D Ultrasound
TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”) (TSXV:VPT) announces that it has received market clearance from the US Food and Drug A...